Real-world evidence: patient views on asthma in respiratory specialist clinics in America

Approximately 30 –50% of patients with moderate/severe asthma have inadequately controlled disease despite adherence to inhaled corticosteroid/long-acting β 2 agonist (ICS/LABA) therapy. Data on prevalence and burden of uncontrolled asthma in specialty settings is lacking.

Source: Annals of Allergy, Asthma and Immunology - December 30, 2020 Category: Allergy & Immunology Authors: John Oppenheimer, David J. Slade, Beth A. Hahn, Laurie Zografos, Alicia Gilsenan, David Richardson, David McSorley, Robson Lima, Nestor A. Molfino, Carlyne M. Averell Source Type: research